ZAP

Apollo Hospital in New Delhi Initiates First Non-Invasive ZAP-X Brain Tumor Treatment in South Asia

Retrieved on: 
Thursday, March 7, 2024

ZAP Surgical Systems, Inc., a leading innovator in the field of surgical robotics, today announced that Apollo Hospital in New Delhi, India, completed its first patient treatment using the new ZAP-X® Gyroscopic Radiosurgery® platform.

Key Points: 
  • ZAP Surgical Systems, Inc., a leading innovator in the field of surgical robotics, today announced that Apollo Hospital in New Delhi, India, completed its first patient treatment using the new ZAP-X® Gyroscopic Radiosurgery® platform.
  • This pioneering approach aims to maximally safeguard healthy brain tissue and preserve patient cognitive function.
  • “Pineal tumors are extremely difficult to remove with open surgery as they are anatomically located within the center of the brain.
  • “ZAP is honored to support Apollo Hospitals in expanding global access to this potentially life-saving treatment.”

ZAP Surgical Announces Additional Installation of Its State-of-the-Art ZAP-X Brain Tumor Treatment System in New York State

Retrieved on: 
Tuesday, March 5, 2024

NSG is a free-standing, privately-owned clinic serving Central New York, the New York Southern Tier, and Northern Pennsylvania.

Key Points: 
  • NSG is a free-standing, privately-owned clinic serving Central New York, the New York Southern Tier, and Northern Pennsylvania.
  • System installation is expected to begin in July, with first patient treatments estimated to commence before the end of the year.
  • “As a procedure with no incisions and no pain, ZAP-X radiosurgery treats patients in what often requires only a single brief outpatient visit.
  • This novel approach aims to maximally safeguard healthy brain tissue and preserve patient cognitive function.

Proprietary product API’s (TCIN, ASIN, EPID) Need Latency Band-Aids For E-Commerce Giants

Retrieved on: 
Thursday, December 7, 2023

Checkout overlays can recover billions of lost revenue daily when liaising with a company's in-house engineer to apply the latency bandaid.

Key Points: 
  • Checkout overlays can recover billions of lost revenue daily when liaising with a company's in-house engineer to apply the latency bandaid.
  • Proprietary product API’s TCIN, ASIN and EPID are relatively new fields with impressive impacts on a company’s bottom line.
  • Winston Hardson, a former UX UI designer and Founder of ZAP Plugin has created an animation-driven API that integrates product and payment screens for a better product experience.
  • Winston founded ZAP Plugin in 2020 because of his passion for resolving one of the most complicated issues of e-commerce giants.

ZAP Surgical Announces Multi-System Order, Broadening Its Brain Tumor Treatment Footprint in the United Kingdom, Germany, and Spain

Retrieved on: 
Thursday, December 21, 2023

Through this agreement, ZAP looks to expand its rapidly growing European installed base with added presence across multiple countries in the region.

Key Points: 
  • Through this agreement, ZAP looks to expand its rapidly growing European installed base with added presence across multiple countries in the region.
  • View the full release here: https://www.businesswire.com/news/home/20231221202014/en/
    As a non-invasive treatment for select brain tumors and brain metastases, stereotactic radiosurgery (SRS) is a well-studied and proven procedure that often provides equivalent to superior outcomes to surgery.
  • This innovative approach ideally aligns with the clinical objective of protecting the patient's healthy brain tissue and preserving cognitive function.
  • Additionally, ZAP-X removes the need to handle, secure, and frequently replace live radioactive isotopes commonly utilized in historical radiation beam production.

ZAP Surgical Deals Two More Blows to Elekta in IP Suit, Removing Barriers to Mass Adoption of the ZAP-X Radiosurgery Platform

Retrieved on: 
Thursday, September 28, 2023

In April 2019, Elekta alleged that the ZAP-X infringed upon its patent 7,296,648, which described a theoretical design for a radiosurgery device that was never brought to market.

Key Points: 
  • In April 2019, Elekta alleged that the ZAP-X infringed upon its patent 7,296,648, which described a theoretical design for a radiosurgery device that was never brought to market.
  • Elekta’s lawsuit against ZAP Surgical sought monetary damages with a three-fold enhancement for willful infringement, as well as an injunction prohibiting the importation, manufacture, use and sales of the ZAP-X.
  • The judicial panel meticulously reviewed Elekta's arguments and found them “unpersuasive”, thus settling the matter conclusively in favor of ZAP Surgical.
  • This German decision echoes the sentiments expressed by the U.S. courts, further strengthening ZAP Surgical's position in this protracted legal battle.

ZAP Surgical Announces Upcoming Installation of Next-Generation ZAP-X Gyroscopic Radiosurgery in Ankara, Turkey

Retrieved on: 
Tuesday, September 26, 2023

ZAP Surgical Systems, Inc., a leading innovator in the field of surgical robotics, today announced that Hacettepe University Hospital in Ankara, Turkey is slated to install the novel ZAP-X® Gyroscopic Radiosurgery® platform before the end of the year.

Key Points: 
  • ZAP Surgical Systems, Inc., a leading innovator in the field of surgical robotics, today announced that Hacettepe University Hospital in Ankara, Turkey is slated to install the novel ZAP-X® Gyroscopic Radiosurgery® platform before the end of the year.
  • View the full release here: https://www.businesswire.com/news/home/20230926608561/en/
    ZAP-X Gyroscopic Radiosurgery platform.
  • For select indications, radiosurgery has proven to provide equivalent to superior outcomes compared to costly and potentially debilitating surgeries.
  • “With the addition of ZAP-X, they will further reinforce their reputation as global center of medical excellence.”

Zinfandel Live Launches a New Series to Explore the Incredible World of Zinfandel

Retrieved on: 
Tuesday, August 1, 2023

ROUGH AND READY, Calif., Aug. 1, 2023 /PRNewswire/ -- Zinfandel Advocates & Producers (ZAP) has launched Zinfandel Live to tell the Zinfandel story in six, short entertaining episodes beginning July 27 on the ZAP YouTube channel. Each bi-monthly episode will feature world-class wines and their winemakers who will lead the viewer to discover the joys of America's Heritage wine—Zinfandel. Hosted by award-winning author, speaker and television personality Leslie Sbrocco, Zinfandel Live is an engaging series into the fascinating world of the Zinfandel grape with Leslie at the helm, breaking down topics into fun, informative short episodes for both casual wine drinkers and those wishing to learn more. The series is sure to open your eyes to the secrets of this multi-faceted delicious wine.

Key Points: 
  • The series is sure to open your eyes to the secrets of this multi-faceted delicious wine.
  • Zinfandel winemakers and famous chefs will be featured throughout the series, all sharing their stories and unique perspectives on Zinfandel; its history and diversity as a world class red wine.
  • Zinfandel Live has partnered with Wine.com to make available for sale a curated selection of the Zinfandels featured in the series through a link on the Zinfandel Live website.
  • In addition, Zinfandel Live also provides links to purchase a wide selection of Zinfandels directly from the wineries.

ZAP Surgical Receives National Medical Products Administration (NMPA) Approval in China

Retrieved on: 
Thursday, June 29, 2023

ZAP Surgical Systems, Inc., a leading innovator in the field of surgical robotics, today announced that the company received National Medical Products Administration (NMPA) approval in China for its ZAP-X® Gyroscopic Radiosurgery® platform.

Key Points: 
  • ZAP Surgical Systems, Inc., a leading innovator in the field of surgical robotics, today announced that the company received National Medical Products Administration (NMPA) approval in China for its ZAP-X® Gyroscopic Radiosurgery® platform.
  • (Photo: Business Wire)
    ZAP-X was previously granted NMPA’s Chinese Medical Device Evaluation (CMDE) Green Pathway, an accelerated path for the examination and approval of innovative medical devices.
  • PLAGH 301 is the largest hospital in China with more than 20,000 outpatient treatments per day.
  • “Following an intensive, multi-year effort we’re incredibly excited that the ZAP-X has finally received its regulatory approval in China,” said Dr. John R. Adler, Stanford Professor of Neurosurgery and Founder & Chief Executive Officer of ZAP Surgical Systems.

ZAP Surgical Announces Upcoming Installation of Novel Non-Invasive Brain Tumor Treatment System in South Korea

Retrieved on: 
Tuesday, June 13, 2023

ZAP Surgical Systems, Inc., a leading innovator in the field of surgical robotics, today announced that Dankook University Hospital (DKUH) in Cheonan, South Korea, is slated to install the novel ZAP-X® Gyroscopic Radiosurgery® platform.

Key Points: 
  • ZAP Surgical Systems, Inc., a leading innovator in the field of surgical robotics, today announced that Dankook University Hospital (DKUH) in Cheonan, South Korea, is slated to install the novel ZAP-X® Gyroscopic Radiosurgery® platform.
  • The new oncology diagnosis and treatment facility is the only cancer center in the region.
  • With the addition of ZAP-X, DKUH will provide the latest advance in brain tumor care to patients throughout the country.
  • “As the sole cancer center in the Chungnam region, we play an important role in the treatment of brain tumors.

First ZAP-X Gyroscopic Radiosurgery Treatments Commence in France

Retrieved on: 
Tuesday, May 23, 2023

ZAP Surgical Systems, Inc., a leading innovator in the field of surgical robotics, today announced that Centre de Cancérologie de la Porte de Saint-Cloud (CCPSC) in Boulogne, France, has initiated patient treatments with the ground-breaking ZAP-X® Gyroscopic Radiosurgery® platform.

Key Points: 
  • ZAP Surgical Systems, Inc., a leading innovator in the field of surgical robotics, today announced that Centre de Cancérologie de la Porte de Saint-Cloud (CCPSC) in Boulogne, France, has initiated patient treatments with the ground-breaking ZAP-X® Gyroscopic Radiosurgery® platform.
  • CCPSC is the first in France to offer ZAP-X and is part of the renowned American Hospital of Paris, known for offering the most innovative technologies and most advanced treatment methods.
  • CCPSC treated three patients on their first day, each with a single brain metastasis.
  • View the full release here: https://www.businesswire.com/news/home/20230523005003/en/
    ZAP-X® Gyroscopic Radiosurgery® treatment suite at Centre de Cancérologie de la Porte de Saint-Cloud (CCPSC), Boulogne, France.